Cardio-Oncology Rehabilitation Care Process

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorHospital Clinico Universitario de Santiago

About this trial

The objective of this observational study is to assess the outcomes of a hospital-based Cardio-Oncology Rehabilitation (CORe) program focused on exercise in cancer patients undergoing cardiotoxic treatment. This evaluation will be conducted by analyzing disease-related health indicators, functional capacity, and quality of life. Patients at risk of cardiotoxicity attending the Cardio-Onco-Hematology Unit will be offered the exercise program, which includes two modalities: in-person (center-based) and remote (home-based) options. The assignment to either modality is non randomized, based on the functional assessment conducted in the Rehabilitation Unit and the agreement between healthcare professional and patient. All participants will perform a 3-month supervised exercise intervention. There are 3 time points for assessment: at baseline (T0), 3-month after the exercise program (T1) and follow-up at 9 months from baseline (T2).

Eligibility criteria

Qualifiers

High risk of cancer treatment-related cardiotoxicity

Possibility of completing a cardio-onco rehabilitation program (centre-based or home-based) and programmed visits.

Providing written informed consent.

Disqualifiers

Patients with physical or mental limitation to carry out an exercise program.

Trial design

Treatments tested in this trial

  • Exercise-based cardio-oncology rehabilitation

Treatment groups

300 Participants
are divided into 2 treatment groups